UPDATE 4-Pfizer CEO says no need to alter its drug pricing practices

NEW YORK, Jan 31 (Reuters) - Pfizer Inc Chief

Executive Ian Read said on Tuesday the company would not change

its philosophy on pricing of its medicines or when it takes

price increases, bucking a recent trend by some rivals of the

largest U.S. drugmaker.

Read more